CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A VON WILLEBRAND FACTOR FVIII CONCENTRATE (VWF/FVIII) DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD)

被引：0
|
作者：
Sidonio, R. [1 ]
Dubey, L. [2 ]
Timofeeva, M. [3 ]
Vilchevska, K. [4 ]
Vdovin, V. [5 ]
Schmid, M. [6 ]
Solomon, C. [6 ]
Knaub, S. [6 ]
机构：
[1] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Hemophilia Georgia Ctr Bleeding & Clotting Disord, Atlanta, GA USA
[2] Lviv Natl Med Univ Danylo Halytskyi, Municipal Inst Western Ukrainian Specialized Chil, Lviv Reg Council, Dept Pediat, Lvov, Ukraine
[3] Minist Hlth Ukraine, State Inst Natl Children Specialized Hosp OKHMATD, Kiev, Ukraine
[4] Fed Med Biol Agcy, Kirov Sci Res Inst Hematol & Blood Transfus, Fed State Budget Inst Sci, Kirov, Russia
[5] Morosovskaya Children Clin Hosp, Moscow Hlth Dept, Dept Gen Hematol Pathol Hemostasis, Moscow, Russia
[6] Octapharma AG, Lachen, Switzerland
来源：
HAEMOPHILIA | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P222
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of a von Willebrand factor concentrate with a low FVIII content in children with von Willebrand disease (vwd)
    Borel-Derlon, A.
    Aronis, S.
    Platokouki, H.
    Maes, P.
    Chatelanaz, C.
    Bridey, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 530 - 530
  • [2] Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)
    Sidonio, Robert F., Jr.
    Schwartz, Bruce A.
    BLOOD, 2019, 134
  • [3] Pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in adults-and children with von Willebrand disease (VWD)
    Di Paola, Jorge
    Lethagen, Stephan
    Gill, Joan
    Mannucci, Pier
    Bemstein, Jonathan
    Nichols, William
    Friedman, Carl
    Knaub, Sigurd
    Bergman, Garrett
    BLOOD, 2007, 110 (11) : 637A - 637A
  • [4] Repetitive infusion of purified von Willebrand factor (vWF) in von Willebrand disease (vWd) results in stable increase of factor FVIII (FVIII) and hemostasis.
    Menache, D
    Aronson, DL
    Montgomery, RR
    Kennedy, ND
    Darr, F
    BLOOD, 1998, 92 (10) : 49A - 49A
  • [5] Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease
    Kuppens, Geoffrey Z. L.
    Fischer, Kathelijn
    van Galen, Karin P. M.
    van Beers, Eduard J.
    van der Valk, Paul R.
    Hovinga, Idske C. L. Kremer
    van Vulpen, Lize F. D.
    Schutgens, Roger E. G.
    HAEMOPHILIA, 2024,
  • [6] Interim Analysis of an Observational Study on Safety and Efficacy of a VWF/FVIII Concentrate in the Management of Von Willebrand Disease
    Khair, K.
    Cruz, M. S.
    Werner, S.
    Knaub, S.
    Von Depka, M.
    Investigators, Study
    HAEMOPHILIA, 2016, 22 : 84 - 85
  • [7] Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease
    Sidonio, Robert F., Jr.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Lissitchkov, Toshko
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia
    BLOOD, 2022, 140 : 8438 - 8439
  • [8] POPULATION PHARMACOKINETIC MODELLING OF VON WILLEBRAND FACTOR ACTIVITY LEVELS DURING PERIOPERATIVE DOSING OF A VWF/FVIII CONCENTRATE IN VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J. M.
    De Jager, N. C.
    Hazendonk, C. H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Gorkom, B. A. Laros-Van
    Leebeek, F. W.
    Cnossen, M. H.
    Mathot, R. A.
    HAEMOPHILIA, 2020, 26 : 23 - 23
  • [9] Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery
    Di Paola, J.
    Lethagen, S.
    Gill, J.
    Mannucci, P.
    Manco-Johnson, M.
    Bernstein, J.
    Nichols, W. L.
    Bergman, G. E.
    HAEMOPHILIA, 2011, 17 (05) : 752 - 758
  • [10] Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
    Srivastava, A.
    Serban, M.
    Werner, S.
    Schwartz, B. A.
    Kessler, C. M.
    HAEMOPHILIA, 2017, 23 (02) : 264 - 272
12345